This narrative review summarizes the literature on factors related to eye care access and
utilization in the United States. Using the Healthy People 2030 framework, this review …

Purpose To assess the safety and efficacy of as-needed (PRN) intravitreal aflibercept
injections (IAI) in managing diabetic retinopathy (DR) guided by the real-time DR severity …

Purpose To evaluate the effect of loss to follow-up (LTFU) on outcomes in eyes with diabetic
macular edema (DME) treated with anti–vascular endothelial growth factor (VEGF). Design …

Age-related macular degeneration (AMD) affects∼ 8.7% of the world's population and is
projected to affect 288 million individuals by the year 2040. 1 The availability of anti …

Introduction There is little understanding of long-term treatment persistence in patients
receiving anti-vascular endothelial growth factor (anti-VEGF) injections for diabetic macular …

Background Although the concept of penile rehabilitation after radical prostatectomy (RP)
has been advocated for decades, there is little definitive evidence regarding its utility or the …

Purpose Clinical trials are often designed to include homogenous, highly specific patient
populations with many resources to reduce patient dropout. Results may not translate to real …

Background: Treatment cessation due to a dry retina has not been systematically addressed
in diabetic macular edema (DME). In three out of four patients receiving 6 mg of …

Пациенты, потерянные для последующего наблюдения (ПДПН),-общепризнанная
проблема, встречающаяся как в клинических испытаниях, так и в реальной клинической …

It is estimated that as of 2019,∼ 463 million adults were living with diabetes mellitus. 1
Approximately 93 million of those patients have some degree of diabetic retinopathy, and up …